Kenneth Horton
Consejero General en SENSEONICS HOLDINGS, INC. .
Fortuna: 813 924 $ al 30/04/2024
Perfil
Kenneth L.
Horton is currently the General Counsel at Senseonics Holdings, Inc. He previously served as the Chairman at Lumira Capital (USA) Corp.
From 2012 to 2015, he was the Chief Legal Officer & Executive Vice President at Vertex Pharmaceuticals, Inc. Kenneth also held the position of VP-Acquisitions, Ventures & General Counsel at Revvity, Inc. Prior to that, he was the EVP-Corporate Development & General Counsel at Nordion (Canada), Inc. from 2005 to 2012.
Mr. Horton completed his undergraduate studies at Dartmouth College and obtained his graduate degree from Harvard Law School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/04/2024 | 1 947 186 ( 0.37% ) | 813 924 $ | 30/04/2024 |
Cargos activos de Kenneth Horton
| Empresas | Cargo | Inicio |
|---|---|---|
| SENSEONICS HOLDINGS, INC. | Consejero General | 01/10/2017 |
Antiguos cargos conocidos de Kenneth Horton.
| Empresas | Cargo | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Consejero General | 20/01/2015 |
| NORDION INC | Consejero General | 01/01/2012 |
| Lumira Capital (USA) Corp. | Presidente | - |
| REVVITY, INC. | Corporate Officer/Principal | - |
Formación de Kenneth Horton.
| Dartmouth College | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| REVVITY, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| Empresas privadas | 2 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
| Lumira Capital (USA) Corp. |
- Bolsa de valores
- Insiders
- Kenneth Horton
